Latest / Medicine Matters: The Springer Medicine Podcast
Episode 2: Progress in PARP inhibitors
An exciting option for treating metastatic prostate cancer?
PARP inhibitors are an emerging treatment option for metastatic castration-resistant prostate cancer and the 2023 ASCO Genitourinary Cancers Symposium saw initial analyses and updates from several trials of these agents that help to address some gaps in the current understanding.
In this episode, Dr. Elena Castro takes us through the latest evidence for PARP inhibitors and their combinations in this setting.
For more on how Springer Medicine can tailor medical education to meet your needs, head to SpringerMedicine.com and register…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.